Vertex Pharma (NASDAQ: VRTX) gained 5% Thursday after AbbVie (NYSE: ABBV) announced the decision to discontinue its cystic fibrosis (CF) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE